Skip to content

Effect of Electrical Stimulation at Acupoints on Blood Pressure

Pilot Study Using Electrical Stimulation on Hypertension

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00459758
Enrollment
40
Registered
2007-04-12
Start date
2007-01-31
Completion date
2007-06-30
Last updated
2007-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

hypertension, Hans, Electrical stimulation

Brief summary

To determine if electrical stimulation on acupoints has any effect on hypertensive subjects.

Detailed description

All subjects will be assigned into control and experimental groups by a random table. The first 40 numbers in the first row will be used for the study. Subjects assigned with an odd number will be divided into the control group. ROLE OF SUBJECTS Subjects in the experimental will receive Hans treatment for hypertension. No invasive procedures will be used for subjects in either the control and experimental groups. This randomized controlled study will recruit hypertensive subjects into control and experimental groups using a random table. Only the subjects in the experimental group use Hans stimulation as a treatment for high blood pressure. The treatment regiment is discussed in the Treatment section in detail. The subjects in the control group will not

Interventions

DEVICEHans unit

Sponsors

Logan College of Chiropractic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of mild hypertension (160-140/100-90 mmHg), male and female subjects with any racial background will be invited to participate in the study. * All adult age groups are included in the study. * Subjects must sign an informed consent form.

Exclusion criteria

* Diagnosis of severe hypertension (200-161/120-101 mmHg), limited physical activity, heart failure, kidney diseases and mental diseases are excluded in the study. A questionnaire will be used in the initial patient screening.

Design outcomes

Primary

MeasureTime frame
Blood pressure measurements.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026